Search by Drug Name or NDC
NDC 58602-0605-42 Alcaftadine 2.5 mg/mL Details
Alcaftadine 2.5 mg/mL
Alcaftadine is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Aurohealth LLC. The primary component is ALCAFTADINE.
MedlinePlus Drug Summary
Ophthalmic alcaftadine is used to relieve the itching of allergic pinkeye. Alcaftadine is in a class of medications called antihistamines. It works by blocking histamine, a substance in the body that causes allergic symptoms.
Related Packages: 58602-0605-42Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Alcaftadine Ophthalmic
Product Information
| NDC | 58602-0605 |
|---|---|
| Product ID | 58602-605_d550d462-ab7c-4703-9e6d-3b2360abac7d |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Alcaftadine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Alcaftadine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | ALCAFTADINE |
| Labeler Name | Aurohealth LLC |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA210659 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 58602-0605-42 (58602060542)
| NDC Package Code | 58602-605-42 |
|---|---|
| Billing NDC | 58602060542 |
| Package | 2 BOTTLE in 1 CARTON (58602-605-42) / 5 mL in 1 BOTTLE |
| Marketing Start Date | 2023-06-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |